Daclizumab induction therapy associated with tacrolimus-Mmf has better outcome compared with tacrolimus-mmf alone in pediatric living donor liver transplantation

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 1151-1152

  Schuller, S ^a   Wiederkehr, J C ^a   Coelho Lemos, I M ^a   Avilla, S G ^a   Schultz, C ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; AGE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FAILURE; LIVER BIOPSY; LIVER GRAFT; LIVER GRAFT REJECTION; LIVING DONOR; LYMPHOPROLIFERATIVE DISEASE; MALE; MEDICAL ASSESSMENT; OBSERVATION; ORGAN DONOR; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEX; TREATMENT FAILURE;

EID: 17844411489     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.01.023     Document Type: Conference Paper

References (7)

1. F. Vincenti, R. Kirkman, S. Light Interleukin blockage with daclizumab to prevent acute rejection N Engl J Med 338 1998 161
2. F. Innocenti, R. Humeres, M. Zamboni IL-2 receptor blockers in liver transplantation: initial experience with daclizumab in Chile Transplant Proc 35 2003 2520
3. R. Hirose, J.P. Roberts, D. Quan Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation Transplantation 69 2000 307
4. D. Eckoff, B. McGuire, M. Sellers The safety and efficacy of a two-dose daclizumab (Zenapax) induction therapy in liver transplant recipients Transplantation 69 2000 1867
5. R. Ganschow, D.C. Broering, I. Stuerenburg First experience with basiliximab in pediatric liver graft recipients Pediatr Transplant 5 2001 353
6. D.A. Kelly The use of anti-interleukin-2 receptor antibodies in pediatric liver transplantation Pediatr Transplant 5 2001 386
7. R.H. Wiesner, J. Demetris, S.H. Belle Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome Hepatology 28 1998 638